HomePASG • NASDAQ
add
Passage Bio Inc
Previous close
$0.54
Day range
$0.50 - $0.56
Year range
$0.45 - $1.79
Market cap
31.19M USD
Avg Volume
224.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.91M | -31.68% |
Net income | -19.34M | 28.66% |
Net profit margin | — | — |
Earnings per share | -0.24 | 40.59% |
EBITDA | -15.11M | 32.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 84.83M | -36.12% |
Total assets | 111.75M | -33.97% |
Total liabilities | 39.04M | -9.18% |
Total equity | 72.72M | — |
Shares outstanding | 61.77M | — |
Price to book | 0.45 | — |
Return on assets | -33.54% | — |
Return on capital | -36.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -19.34M | 28.66% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Headquarters
Website
Employees
58
